ClinicalTrials.Veeva

Menu

Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment

S

Shanghai Jiao Tong University School of Medicine

Status and phase

Completed
Phase 4

Conditions

Peptic Ulcer
Functional Dyspepsia

Treatments

Drug: Bismuth
Drug: Levofloxacin
Drug: Lansoprazole
Drug: Amoxicillin

Study type

Interventional

Funder types

Other

Identifiers

NCT01667718
rjkls2012011

Details and patient eligibility

About

To examine and compare the efficacy of 2 week Levofloxacin-containing therapies with and without Bismuth for H.pylori treatment.

Full description

The success rate of the standard triple therapy for H. pylori infection is decreasing recently.Fluoroquinolone has been proposed to replace clarithromycin as an alternative in the treatment. However prevalence of H.pylori resistance to Levofloxacin has increased rapidly in our area. The purpose of this study is to observe the efficacy of 14 day Levofloxacin triple therapy-based, bismuth-containing quadruple therapy for H.pylori treatment.

Enrollment

161 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients who presented with upper gastrointestinal symptoms and endoscopically proven H.pylori-positive functional dyspepsia and scarred peptic ulcer

Exclusion criteria

  • patients with peptic ulcer, previous H.pylori eradication therapy, previous gastric surgery, pregnancy, lactation, major systemic diseases, receipt of anti-secretory therapy, antibiotics or bismuth in the preceding 4 weeks, or allergy to any one of the medications

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

161 participants in 2 patient groups

Levofloxacin-triple therapy
Active Comparator group
Description:
Lansoprazole (Proton Pump Inhibitor), Levofloxacin, Amoxicillin
Treatment:
Drug: Amoxicillin
Drug: Lansoprazole
Drug: Levofloxacin
Levofloxacin-quadruple therapy
Experimental group
Description:
Lansoprazole (Proton Pump Inhibitor),Bismuth, Levofloxacin, Amoxicillin
Treatment:
Drug: Amoxicillin
Drug: Lansoprazole
Drug: Bismuth
Drug: Levofloxacin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems